These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4674910)

  • 1. Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.
    Rocklin RE; Remold HG; David JR
    Cell Immunol; 1972 Nov; 5(3):436-45. PubMed ID: 4674910
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification and characterization of lymphocyte mediators in cellular immunity: comparative studies on migration inhibitory factor (MIF) chemotactic factor for macrophages and lymphotoxin.
    Remold HG
    Transplant Rev; 1972; 10():152-76. PubMed ID: 4342436
    [No Abstract]   [Full Text] [Related]  

  • 4. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.
    David JR; Coyne JA; Rocklin RE; Nathan CF; Remold HG
    Transplant Proc; 1972 Jun; 4(2):241-2. PubMed ID: 4113698
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
    Remold HG; Katz AB; Haber E; David JR
    Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature.
    Remold HG; David JR
    J Immunol; 1971 Oct; 107(4):1090-8. PubMed ID: 4106089
    [No Abstract]   [Full Text] [Related]  

  • 7. Guinea pig lymphotoxin (LT). II. Physicochemical properties of LT produced by lymphocytes stimulated with antigen or concanavalin A: its differentiation from migration-inhibitory factor (MIF).
    Coyne JA; Remold HG; Rosenberg SA; David JR
    J Immunol; 1973 Jun; 110(6):1630-7. PubMed ID: 4123284
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of migration inhibitory factor (MIF) and its separation from a chemotactic factor for monocytes.
    Remold HG; Ward P; David JR
    Int Arch Allergy Appl Immunol; 1971; 41(1):16-7. PubMed ID: 5560974
    [No Abstract]   [Full Text] [Related]  

  • 9. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.
    Ward PA; Remold HG; David JR
    Cell Immunol; 1970 Jul; 1(2):162-74. PubMed ID: 4108781
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a lymphocyte factor which alters macrophage functions.
    Nathan CF; Remold HG; David JR
    J Exp Med; 1973 Feb; 137(2):275-90. PubMed ID: 4119587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on macrophage migration inhibitory factor.
    Yoshida T
    Jpn J Med Sci Biol; 1971 Jun; 24(3):190. PubMed ID: 5315161
    [No Abstract]   [Full Text] [Related]  

  • 16. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
    Leu RW; Eddleston AL; Hadden JW; Good RA
    J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a lymphocyte inhibition factor from human serum.
    Ford WH; Caspary EA; Shenton B
    Clin Exp Immunol; 1973 Oct; 15(2):169-79. PubMed ID: 4762015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial characterization of murine migration inhibitory factor (MIF).
    Kühner AL; David JR
    J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
    Yoshida T; Bigazzi P; Cohen S
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1641-4. PubMed ID: 165520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.